FOLH1 and prostate cancer: Before the introduction of PSMA PET, prostate cancer molecular imaging was commonly performed using radiolabeled choline-ligands (e.g., 11C-choline and 18F-choline) and more recently 18F-Fluciclovine [15,44,45,46,47].